Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
EPA Unveils Strategy For Commercial Chemical Evaluations January 18, 2017 Russell Maas Add Your Comments Federal environmental safety officials have announced three new rules that are designed to form the backbone of a strategy that will evaluate and regulate new chemicals, to help determine potential risks to the public health and environment. The Environmental Protection Agency (EPA) announced the proposed rules on January 13, which would establish the first-ever, comprehensive regulatory strategy for chemicals entering U.S. commerce. The three new rules follow the passing of The Frank R. Lautenberg Chemical Safety for the 21st Century Act, which was signed into law by President Barack Obama on June 22, 2016, as the first update to the Toxic Substances Control Act (TSCA) since it was originally enacted in 1976. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In addition to the new “foundational” rules, the EPA has also proposed three rules restricting specific high risk uses of a number of chemicals. The rules must be finalized by June 2017, according to mandates set in the new chemical law. Oversight and regulation has become a necessity for chemicals entering U.S. commerce, given the new technology and scientific developments that prove certain popular household chemicals used heavily over the last forty years may actually be harmful and cause diseases from overexposure, experts say. The EPA indicates that the proposed rules will set into motion a process designed to quickly evaluate chemicals that have been entered into commerce over the last decade, by granting them the authority to identify chemicals made in, imported into or processed within the U.S. The EPA will decide which of those have potential health and environmental risks through the use of scientific data and assess those risks and pursue regulatory controls as needed. As part of the new rules, the EPA will be required to systemically prioritize existing chemical substances that have entered the market within the past 10 years. The new process will be managed by the EPA’s Office of Chemical Safety and Pollution Prevention and Office of General Counsel. The American Chemistry Council released a statement praising the EPA for their fast development and implementation of the new chemical evaluation rules. Since Congress last amended the TSCA when it was enacted into law in 1976, tens of thousands of chemicals were automatically grandfathered into production as presumable safe materials without any federal or scientific evaluation to assess their risk to human or environmental risks. According to prior research by the EPA, of the 85,000 known chemicals, about 1,000 are used in everyday consumer products and are in need of safety reevaluation. The EPA placed 90 chemicals known to pose health risks on a list called the TSCA Work Plan and intends to place those chemicals high on its prioritization list. Included in the EPA’s new rules, the agency has set specific agendas for certain chemicals, particularly for paint and coating removal uses of two solvents, methylene chloride and n-methylpyrrolide, dry cleaning and aerosol degreasing uses of other solvents including trichloroethylene, and the vapor degreasing uses of trichloethylene. In December, the EPA announced ten chemicals it was making a priority to review, including asbestos and dioxane. When a chemical is deemed to pose an unreasonable risk the EPA must take action within two years, with the possibility of an extension to four years. Bans and phaseouts have to occur within five years of an assessment that a chemical is unreasonably dangerous. For new chemicals, the EPA must review and declare that a chemical is safe before it is allowed on the marketplace and can ban, require additional testing, or place limitations on new chemicals and their uses. Much of the funding will come from chemical manufacturer user fees. When a manufacturer wants their chemical tested, they must pay 50% of the cost if it’s already on the EPA’s agenda, or 100% if the EPA has not yet scheduled a review. They will pay fees for submitting test data, for notices of new chemicals, and other activities. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Asbestos, Chemicals, Congress, Dioxane, EPA More Lawsuit Stories Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects November 26, 2025 Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 November 26, 2025 Walmart Christmas Lights Lawsuit Alleges ‘Holiday Time’ LED Bulbs Overheated, Caused Fire November 26, 2025 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: today) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: yesterday) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 2 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
Walmart Christmas Lights Lawsuit Alleges ‘Holiday Time’ LED Bulbs Overheated, Caused Fire November 26, 2025
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: today) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: yesterday) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 2 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)